{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:16:51Z","timestamp":1758637011477},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.thromres.2012.05.017","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T01:47:59Z","timestamp":1339206479000},"page":"e26-e30","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome"],"prefix":"10.1016","volume":"130","author":[{"given":"L. Barry","family":"Seltz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh Anne","family":"Bakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Tiehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2012.05.017_bb0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of shiga-toxin associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0010","first-page":"1073","article-title":"Shiga-toxin producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.05.017_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOG.0b013e3282f2dfb8","article-title":"Pathogenesis and treatment of shiga toxin-producing Escherichia coli infections","volume":"24","author":"Serna","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00431-009-1039-4","article-title":"Today's understanding of the haemolytic uraemic syndrome","volume":"169","author":"Scheiring","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.thromres.2005.07.013","article-title":"Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"118","author":"Franchini","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.05.017_bb0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s004670100660","article-title":"Pathogenesis of shiga toxin-induced hemolytic uremic syndrome","volume":"16","author":"Ray","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0035","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","article-title":"Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction","volume":"25","author":"Zoja","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9343(79)91190-2","article-title":"The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function","volume":"66","author":"Thorsen","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2012.05.017_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0022-3476(75)80235-6","article-title":"Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole","volume":"86","author":"Arenson","year":"1975","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(73)91815-1","article-title":"Haemolytic uraemic syndrome in women taking oral contraceptives","volume":"1","author":"Brown","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2012.05.017_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3476(74)80714-6","article-title":"Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome","volume":"84","author":"Powell","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(88)80031-3","article-title":"Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: A prospective, randomized study","volume":"113","author":"Damme-Lombaerts","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-3476(80)80210-1","article-title":"Aspirin and dipyridamole therapy in the hemolytic uremic syndrome","volume":"97","author":"O'Regan","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.thromres.2011.04.010","article-title":"Pharmacogenomics of clopidogrel: evidence and perspectives","volume":"128","author":"Yin","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2012.05.017_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2007.12.050","article-title":"Safety and efficacy of clopidogrel in children with heart disease","volume":"153","author":"Mertens","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jpeds.2005.05.006","article-title":"Clopidogrel use in children","author":"Finkelstein","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0085","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/01.STR.0000209620.44017.97","article-title":"The risks and safety of clopidogrel in pediatric arterial ischemic stroke","volume":"37","author":"Soman","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2012.05.017_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00246-008-9289-x","article-title":"Clopidogrel in a pediatric population: prescribing practice and outcomes from a single center","volume":"30","author":"Maltz","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0095","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1136\/hrt.2004.039214","article-title":"Thrombotic thrombocytopenic purpura\/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases","volume":"90","author":"Andersohn","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2012.05.017_bb0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1592\/phco.24.6.664.34732","article-title":"Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting","volume":"24","author":"Manor","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2012.05.017_bb0105","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archinte.160.9.1370","article-title":"Hemolytic uremic syndrome associated with clopidogrel: a case report","volume":"160","author":"May","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2012.05.017_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mjt.0000212708.81034.22","article-title":"Hematologic adverse effects of clopidogrel","volume":"14","author":"Balamuthusamy","year":"2007","journal-title":"Am J Ther"},{"key":"10.1016\/j.thromres.2012.05.017_bb0115","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2012.05.017_bb0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00431-009-1079-9","article-title":"The Swiss Pediatric Surveillance Unit. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997\u20132003","volume":"169","author":"Schifferli","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.thromres.2012.05.017_bb0125","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"The Escape Trial Group","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2012.05.017_bb0130","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00467-010-1598-7","article-title":"Validation of the revised Schwartz estimation equation in a predominantly non-CKD population","volume":"25","author":"Staples","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.thromres.2012.05.017_bb0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials","volume":"53","author":"Michael","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.thromres.2012.05.017_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.thromres.2012.05.017_bb0145","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/ki.2008.628","article-title":"An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic","volume":"75","author":"Matsell","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.thromres.2012.05.017_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V60.3.564.564","article-title":"Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet \u201cexhaustion\u201d","volume":"60","author":"Fong","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.05.017_bb0155","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.2010.1566","article-title":"Clopidogrel and the reduced-function CYP2C19 genetic variant. A limited piece of the overall therapeutic puzzle","volume":"304","author":"Fuster","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2012.05.017_bb0160","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome. A systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T17:50:24Z","timestamp":1594230624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0049384812002393"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.05.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}